Vortex Surgical 25GA Backflush, VS0270.25; 25GA Backflush Retractable, VS0275.27 Recall
Vortex Surgical 25GA Backflush, VS0270.25; 25GA Backflush Retractable, VS0275.27
FDA recall Class II
Ongoing
FDA lists this Class II recall for Vortex Surgical 25GA Backflush, VS0270.25; 25GA Backflush Retractable, VS0275.27. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1255-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Dec 16, 2025
- FDA report date
- Feb 11, 2026
- Quantity in commerce
- 14,789 (8651 US; 6138 OUS)
- Distribution
- See key details
- FDA cause
- Employee error
What is being recalled?
Vortex Surgical 25GA Backflush, VS0270.25; 25GA Backflush Retractable, VS0275.27
Affected model & UDI checker
Search the exact identifiers published for Z-1255-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | Vortex Surgical 25GA Backflush, VS0270.25; 25GA Backflush Retractable, VS0275.27 | Check source notice | 810123480470 |
| Not specified | Vortex Surgical 25GA Backflush, VS0270.25; 25GA Backflush Retractable, VS0275.27 | Check source notice | 810123480753 |
| Not specified | Vortex Surgical 25GA Backflush, VS0270.25; 25GA Backflush Retractable, VS0275.27 | Check source notice | 810123480517 |
| Not specified | Vortex Surgical 25GA Backflush, VS0270.25; 25GA Backflush Retractable, VS0275.27 | Check source notice | 810123480791 |
FDA code information
25GA Backflush Pouch UDI 810123480470 Box UDI 810123480753 Lot 2411017; 27GA Backflush Retractable Pouch UDI 810123480517 Box UDI 810123480791 Lot 2411016
Why was this product recalled?
There may be voids located in the seal of Tyvek pouches associated with identified catalog numbers and lots. A compromised sterile barrier has potential of bioburden contamination which could lead to infection.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Vortex Surgical Inc. take?
On December 16, 2025, the firm began notifying customers via "URGENT: MEDICAL DEVICE RECALL" letters. Customers were instructed to discontinue use of affected product and to return product for Vortex Surgical to evaluate the seals; use UPS account 23623Y to ship unused products to Vortex Surgical Inc for replacement or refund at: Attn: Andrew Ritts Recall Tyvek Seal, Vortex Surgical Inc., 4 Research Park Dr., Suite 124, St. Charles, MO 63304; complete and return the Acknowledgement and Receipt Form via mail or email to: ARitts@VortexSurgical.com. Actions have been implemented to improve training of individuals associated with sealing and inspecting seals to prevent reoccurrence. The sealer associated with the issue is being updated to include a guard to prevent reoccurrence. If you have any questions, contact the Director of Regulatory Affairs at 635-778-4350 or email to: ARitts@VortexSurgical.com from 8am to 5pm.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1255-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology